STAMFORD, Conn. and HOUSTON, Dec. 18, 2024 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA) and Tvardi Therapeutics, Inc. ("Tvardi"), a privately held ...
Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks! Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks An update from Cara Therapeutics ( ...
Shares of nanocap pharma Cara Therapeutics (NASDAQ:CARA) added ~11% in the premarket on Wednesday after the company agreed to merge with privately held biopharma Tvardi Therapeutics in an all-stock ...
STAMFORD, Conn., Dec. 27, 2024 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA) (the "Company"), today announced that a 1-for-12 reverse stock split of its outstanding shares of common stock ...
MILWAUKEE--(BUSINESS WIRE)--Ademi LLP is investigating Cara (NASDAQ: CARA) for possible breaches of fiduciary duty and other violations of law in its transaction with Tvardi. Click here to learn how ...
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of Cara ...
(RTTNews) - Cara Therapeutics, Inc. (CARA), a biopharmaceutical company focused on pruritus treatments, has announced the effective date of a 1-for-12 reverse stock split. Cara's common stock begined ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results